Literature DB >> 10493588

Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

R M Arduini1, K L Strauch, L A Runkel, M M Carlson, X Hronowski, S F Foley, C N Young, W Cheng, P S Hochman, D P Baker.   

Abstract

The extracellular portions of the chains that comprise the human type I interferon receptor, IFNAR1 and IFNAR2, have been expressed and purified as recombinant soluble His-tagged proteins, and their interactions with each other and with human interferon-beta-1a (IFN-beta-1a) were studied by gel filtration and by cross-linking. By gel filtration, no stable binary complexes between IFN-beta-1a and IFNAR1, or between IFNAR1 and IFNAR2 were detected. However, a stable binary complex formed between IFN-beta-1a and IFNAR2. Analysis of binary complex formation using various molar excesses of IFN-beta-1a and IFNAR2 indicated that the complex had a 1:1 stoichiometry, and reducing SDS-PAGE of the binary complex treated with the cross-linking reagent dissucinimidyl glutarate (DSG) indicated that the major cross-linked species had an apparent Mr consistent with the sum of its two individual components. Gel filtration of a mixture of IFNAR1 and the IFN-beta-1a/IFNAR2 complex indicated that the three proteins formed a stable ternary complex. Analysis of ternary complex formation using various molar excesses of IFNAR1 and the IFN-beta-1a/IFNAR2 complex indicated that the ternary complex had a 1:1:1 stoichiometry, and reducing SDS-PAGE of the ternary complex treated with DSG indicated that the major cross-linked species had an apparent Mr consistent with the sum of its three individual components. We conclude that the ternary complex forms by the sequential association of IFN-beta-1a with IFNAR2, followed by the association of IFNAR1 with the preformed binary complex. The ability to produce the IFN-beta-1a/IFNAR2 and IFN-beta-1a/IFNAR1/IFNAR2 complexes make them attractive candidates for X-ray crystallography studies aimed at determining the molecular interactions between IFN-beta-1a and its receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493588      PMCID: PMC2144400          DOI: 10.1110/ps.8.9.1867

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  59 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

2.  Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis.

Authors:  E Thoreau; B Petridou; P A Kelly; J Djiane; J P Mornon
Journal:  FEBS Lett       Date:  1991-04-22       Impact factor: 4.124

3.  Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons.

Authors:  J John; R McKendry; S Pellegrini; D Flavell; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

Review 6.  The interferon genes.

Authors:  C Weissmann; H Weber
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1986

7.  Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor.

Authors:  C H Yang; W Shi; L Basu; A Murti; S N Constantinescu; L Blatt; E Croze; J E Mullersman; L M Pfeffer
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

8.  Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.

Authors:  G Uzé; G Lutfalla; I Gresser
Journal:  Cell       Date:  1990-01-26       Impact factor: 41.582

9.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

10.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

Authors:  B C Cunningham; M Ultsch; A M De Vos; M G Mulkerrin; K R Clauser; J A Wells
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

View more
  6 in total

1.  Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.

Authors:  Christopher D Krause; Gina Digioia; Lara S Izotova; Junxia Xie; Youngsun Kim; Barbara J Schwartz; Olga V Mirochnitchenko; Sidney Pestka
Journal:  Cytokine       Date:  2013-07-03       Impact factor: 3.861

2.  Antiviral activities of the soluble extracellular domains of type I interferon receptors.

Authors:  C S Han; Y Chen; T Ezashi; R M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

3.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

Review 4.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

Review 5.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

6.  Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.

Authors:  Cedric E Bobst; Rinat R Abzalimov; Damian Houde; Marek Kloczewiak; Rohin Mhatre; Steven A Berkowitz; Igor A Kaltashov
Journal:  Anal Chem       Date:  2008-08-27       Impact factor: 6.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.